Search results
Arbutus, Novavax See Activist Investor Action
Barrons.com· 1 day agoMcElhaugh’s statement that Arbutus doesn’t anticipate further at-the-market share issuances this year due to its substantial cash balance and liquidity....
The growing promise of cancer vaccines
Cosmos· 3 hours agoA cure for cancer — which is second only to cardiovascular diseases in its contribution to the global burden of disease — has long been a dream. While no magic bullet is yet in sight, three ...
Bird Flu Cases Spur Retail Trader Rush Into Vaccine Stocks
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- Mounting cases of bird flu in humans is luring the day trading crowd to snap up stock...
Biotech stocks are rising alongside bird flu fears
Semafor via Yahoo Finance· 2 days agoVaccine makers, including Moderna, BioNTech, and CureVac, all saw double-digit stock increases, as investors bet they could cash in on a public health...
Moderna, CureVac, other vaccine stocks jump as new human bird-flu cases reported in U.S., Australia
Market Watch· 3 days agoVaccine-related stocks moved sharply higher Wednesday as new human bird-flu cases were reported in...
Novavax awaits FDA decision on whether its next COVID shot can be offered in US
Reuters via Yahoo News· 1 day agoNovavax will only be able to offer a COVID-19 vaccine in the United States this autumn if regulators...
Pfizer wins cancer drug patent case against AstraZeneca
Pharmaceutical Technology via Yahoo Finance· 6 days agoPfizer and BioNTech were sued by Moderna in 2022. It accused them of using its patented mRNA...
The West should be on a war footing for the next pandemic
The Telegraph via Yahoo News· 4 days agoPeople have been quick to forget how bad the pandemic was, but it’s important to remember the scale...
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 3 days agoAccording to a report from NBC News, experts predict a small rise in COVID-19 cases as a newly...
CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update
Morningstar· 3 days agoOrganizational redesign on track, trimming residual pandemic infrastructure and reducing 150 positions by year endU.S. FDA Fast Track designation granted for pre-pandemic avian influenza (H5N1 ...
